Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Tecartus led to durable remission in a majority of participants in a Phase II study.
Six years after his diagnosis with chronic lymphocytic leukemia, Jeff Neurman blogs and cohosts a podcast for men with cancer.
September was designated as National Blood Cancer Awareness Month in 2010 by United States Congress.
Imbruvica plus Rituxan delayed disease progression when compared with a triple chemotherapy regimen.
Customized treatments demonstrate good response rates for mantle cell lymphoma and chronic lymphocytic leukemia.
In my post-diagnosis, post-chemo world, irrational anxiety has become my near-constant companion.
I was recently reminded — repeatedly — by my 10-year-old son of how much my cognitive ability has been impacted by cancer and chemo.
Perhaps more fundamentally, being otherwise occupied has distracted me to a degree from the omnipresence of cancer.
There is something so profoundly altering about being diagnosed with cancer that it results in a new understanding of what is important.
I can’t think of a single positive reason one would ever go to an oncologist.
I have a steadfast belief that the last place one wants to be when ill is at the hospital—After all, there are sick people there.
Imbruvica, Calquence and Venclexta demonstrate good results in combination regimens.
Calquence is the second therapy approved under a new program that lets companies simultaneously apply for approval in multiple countries.
Just because I look quite healthy does not mean that I am. To quote my oncologist prior to chemo, “You had no idea how sick you were.”
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.